Lv3
228 积分 2022-10-07 加入
Pulmonary enteric adenocarcinoma
1个月前
已完结
WHO classification of breast tumours (5th edition)
1个月前
已关闭
Re: WHO Classification of Tumours, 5th Edition, Volume 8: Urinary and Male Genital Tumours
1个月前
已完结
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions
1个月前
已完结
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations
1个月前
已完结
Sunvozertinib monotherapy versus platinum-based chemotherapy as first-line treatment for advanced NSCLC with EGFR exon20ins: Primary analysis of a multinational phase 3 randomized study (WU-KONG28)
1个月前
已完结
Patient-reported outcomes and time to symptomatic progression from PAPILLON: amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated advanced NSCLC
1个月前
已完结
Application of thrombopoietic agents in cancer therapy-induced thrombocytopenia: A comprehensive review
2个月前
已完结
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study
9个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
11个月前
已完结
皖公网安备34019202002308
